ExploreWatchlistsPricing
  1. JP-listed companies
  2. ASKA Pharmaceutical Holdings CO., Ltd.
  3. Financials
  4. EBITDA

ASKA Pharmaceutical Holdings CO., Ltd. (4886)

Market cap
¥78.3B
P/E ratio
15.5x
Asuka Pharmaceutical Holdings operates through subsidiaries that manufacture prescription drugs, veterinary medicines, and medical devices for healthcare providers globally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 20257,578-17.29%
Mar 31, 20249,162+11.26%
Mar 31, 20238,235+7.23%
Mar 31, 20227,680

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat